Chugai Pharmaceutical Co., Ltd.
CHGCF
$42.03
-$1.06-2.45%
OTC PK
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 1.30B | 1.98B | 2.21B |
| Total Depreciation and Amortization | -- | -- | 199.69M | 202.46M | 215.04M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -1.69B | -1.44B | -1.01B |
| Change in Net Operating Assets | -- | -- | 3.28B | 1.98B | 1.25B |
| Cash from Operations | -- | -- | 3.10B | 2.72B | 2.66B |
| Capital Expenditure | -- | -- | -447.37M | -393.13M | -397.16M |
| Sale of Property, Plant, and Equipment | -- | -- | 47.59M | -4.11M | 119.16M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -856.50M | -1.44B | 43.19M |
| Cash from Investing | -- | -- | -1.26B | -1.84B | -234.81M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 4.01B | 1.98B | -- |
| Issuance of Common Stock | -- | -- | 200.00M | 208.00M | 171.00M |
| Repurchase of Common Stock | -- | -- | -7.00M | -8.00M | -7.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -1.07B | -1.07B | -896.17M |
| Other Financing Activities | -- | -- | -11.99B | -10.00B | -7.90B |
| Cash from Financing | -- | -- | -1.12B | -1.12B | -949.77M |
| Foreign Exchange rate Adjustments | -- | -- | -9.53M | -10.03M | 36.32M |
| Miscellaneous Cash Flow Adjustments | -- | -- | 6.90K | -5.90K | 7.20K |
| Net Change in Cash | -- | -- | 705.74M | -247.66M | 1.51B |